2022 BIO One-on-One Partnering at JPM Week; Virtual Partnering Meetings; January 10-14 | ASC

Virtually join us during the 2022 BIO One-on-One Partnering event at JPM week. Schedule your meeting with Applied StemCell’s technical experts today using the BIO One-on-One Partnering™ system. We look forward to connecting with you.

When: January 10-14, 2022

Where: Virtual

Register: https://www.bio.org/events/bio-partnering-jpm/registration?mkt_tok=NDkwLUVIWi05OTkAAAGAgHLi3LLIaq0165dL76IGlmupdxTwe52rY463Wo2y3sL7UPYKXsRGHbiK6R96Fq03WhI-LAhtqctuq4j4DvWFLeWfozBcaC8yKAsZWV0RTSmS

About Applied StemCell, Inc.

Applied StemCell, Inc. (ASC) is a fast-growing Gene & Cell Therapy CRO headquartered in California, USA. ASC was founded in 2008 with a goal to advance gene-editing and stem cell innovation for biomedical research and the biotechnology industry. With more than 12 years of experience in genome editing and stem cell technologies, ASC is proud to develop innovative technology platforms offering services and products in the field of Stem Cells (iPSCs/ESCs, differentiated cells) and animal/cell models for disease modeling, antibody discovery & screening, bioproduction, AAV potency assays, cell therapy, and regenerative medicine. Our Cell and Gene Therapy Bioservice platform also includes consultation for Pre-IND filing and CMC processes.

More information can be found at www.appliedstemcell.com.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.